Lung Cancer | Proceedings from a daylong symposium hosted in partnership with Florida Cancer Spec… [Video]

Proceedings from a daylong symposium hosted in partnership with Florida Cancer Specialists, featuring key clinical presentations and papers in lung cancer. Featuring perspectives from Drs Lecia Sequist and David Spigel, including the following topics:

• Introduction

• Case: A woman in her early 70s with microsatellite stable metastatic adenocarcinoma of the lung and a HER2 mutation, PD-L1 TPS 0% — Dr Zafar

• Case: A man in his mid-80s with localized adenocarcinoma of the lung and an EGFR exon 19 deletion — Dr Gandhi

• Case: A woman in her late 70s with metastatic adenocarcinoma of the lung, somatic BRCA2 and KRAS G12C mutations and high tumor mutation burden (TMB) — Kapisthalam (KS) Kumar, MD

• Targeted Therapy for Lung Cancer Chalk Talk — Dr Spigel

• Case: A man in his mid-60s with Stage IIIA (8-cm, node-negative) adenocarcinoma of the lung — Shachar Peles, MD

• Case: A man in his mid-50s with Stage IIIA adenocarcinoma of the lung — Dr Choksi

• Case: A woman in her mid-60s with metastatic adenocarcinoma of the lung, PD-L1 56% — Dr Gandhi

• First-Line Treatment of PD-L1-Negative Metastatic NSCLC without a Targetable Mutation Chalk Talk — Dr Sequist

• Selecting Patients with Localized NSCLC for Adjuvant Immunotherapy Chalk Talk — Dr Spigel

• Case: A man in his early 50s with extensive-stage small cell lung cancer (SCLC) — Dr Apuri

• Case: A man in his mid-60s with extensive-stage SCLC and concurrent prostate cancer — Dr Gandhi

CME information and select publications (http://m.researchtopractice.com/FCS2021/Video)